Does LORAZEPAM Cause Interstitial lung disease? 31 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Interstitial lung disease have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.
31
Reports of Interstitial lung disease with LORAZEPAM
0.1%
of all LORAZEPAM reports
15
Deaths
20
Hospitalizations
How Dangerous Is Interstitial lung disease From LORAZEPAM?
Of the 31 reports, 15 (48.4%) resulted in death, 20 (64.5%) required hospitalization, and 1 (3.2%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LORAZEPAM Alternatives Have Lower Interstitial lung disease Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN